DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors-Reference-Cited by-同舟云学术

DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors

Published:2017-04-24 Issue:10 Volume:19 Page:1372-1379
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Brown Austin L,Foster Kayla L,Lupo Philip J,Peckham-Gregory Erin C,Murray Jeffrey C,Okcu M Fatih,Lau Ching C,Rednam Surya P,Chintagumpala Murali,Scheurer Michael E

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/10/1372/19784781/nox076.pdf

Reference42 articles.

1. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development;J Clin Oncol,2005

2. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study;Cancer,2015

3. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children’s Oncology Group;Children’s Oncology Group;Pediatrics,2007

4. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma;J Clin Oncol,2008

5. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption;Pediatr Blood Cancer,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4;MedComm;2024-09

2. A systematic review on the contribution of DNA methylation to hearing loss;Clinical Epigenetics;2024-07-05

3. Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping review;Cancer Medicine;2024-07

4. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma;Neuro-Oncology;2024-06-25

5. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review;International Journal of Radiation Oncology*Biology*Physics;2023-10